ACIU Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . AC Immune
ACIU Stock  USD 2.24  0.03  1.36%   
AC Immune financial statements provide useful quarterly and yearly information to potential AC Immune investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on AC Immune financial statements helps investors assess AC Immune's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting AC Immune's valuation are summarized below:
Gross Profit
-35.3 M
Profit Margin
(1.86)
Market Capitalization
221.9 M
Enterprise Value Revenue
1.3602
Revenue
27.3 M
There are currently one hundred twenty fundamental measures for AC Immune that can be evaluated and compared over time across peers in the sector. All traders should validate AC Immune's latest fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 256.3 M in 2025. Enterprise Value is likely to drop to about 227 M in 2025

AC Immune Total Revenue

20.14 Million

Check AC Immune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AC Immune's main balance sheet or income statement drivers, such as Interest Expense of 126.3 K, Selling General Administrative of 8.7 M or Total Revenue of 20.1 M, as well as many indicators such as Price To Sales Ratio of 9.38, Dividend Yield of 0.0 or PTB Ratio of 2.28. ACIU financial statements analysis is a perfect complement when working with AC Immune Valuation or Volatility modules.
  
Check out the analysis of AC Immune Correlation against competitors.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

AC Immune Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets184 M230.9 M139.3 M
Slightly volatile
Other Current Liabilities9.8 M12.1 M8 M
Slightly volatile
Total Current Liabilities105.9 M100.8 M22.4 M
Slightly volatile
Total Stockholder Equity155.6 M112.3 M116.5 M
Slightly volatile
Other Liabilities5 M3.7 M3.8 M
Slightly volatile
Net Tangible Assets145.5 M136.4 M108.5 M
Slightly volatile
Accounts Payable1.9 M2.7 M1.7 M
Pretty Stable
Cash34.5 M36.3 M73.5 M
Slightly volatile
Other Assets234.4 K415.1 K211.7 K
Slightly volatile
Net Receivables3.8 M2.2 M3.9 M
Very volatile
Other Current Assets3.1 M4.3 M2.3 M
Slightly volatile
Total Liabilities124.6 M118.6 M28.8 M
Slightly volatile
Total Current Assets160.5 M172 M121.7 M
Slightly volatile
Common Stock1.6 M2.2 M1.3 M
Slightly volatile
Property Plant Equipment8.5 M8.1 M3.9 M
Slightly volatile
Property Plant And Equipment Net5.1 M8.1 M3.6 M
Slightly volatile
Current Deferred Revenue89.3 M85.1 M11.4 M
Slightly volatile
Non Current Assets Total61.9 M58.9 M20 M
Slightly volatile
Non Currrent Assets Other394.4 K415.1 K607.9 K
Pretty Stable
Cash And Short Term Investments164.7 M165.5 M114 M
Slightly volatile
Common Stock Total Equity1.3 M1.8 M1.2 M
Slightly volatile
Common Stock Shares Outstanding76.7 M100.9 M66.6 M
Slightly volatile
Liabilities And Stockholders Equity199.4 M230.9 M144.7 M
Slightly volatile
Non Current Liabilities Total18.7 M17.8 M6.8 M
Slightly volatile
Capital Surpluse235.2 M398.5 M227.3 M
Slightly volatile
Other Stockholder Equity320.7 M478.3 M241.6 M
Slightly volatile
Property Plant And Equipment Gross21.6 M20.6 M6.6 M
Slightly volatile
Net Invested Capital145.8 M112.3 M151.5 M
Slightly volatile
Net Working Capital127.5 M71.2 M140 M
Pretty Stable
Capital Stock1.9 M2.2 M1.6 M
Slightly volatile

AC Immune Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative8.7 M11.4 M7 M
Slightly volatile
Total Revenue20.1 M27.3 M21.8 M
Very volatile
Cost Of Revenue45.8 M62.8 M38.7 M
Slightly volatile
Total Operating Expenses53.5 M79.7 M43.6 M
Slightly volatile
Depreciation And Amortization1.5 M2.2 M1.1 M
Slightly volatile
Other Operating Expenses61.8 M79.7 M47.4 M
Slightly volatile
Research Development48.6 M62.6 M37.4 M
Slightly volatile
Interest Income3.4 M3.2 M1.6 M
Pretty Stable
Reconciled Depreciation2 M2.2 M1.3 M
Slightly volatile

AC Immune Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.8 M5.5 M2.1 M
Slightly volatile
Begin Period Cash Flow100.1 M78.5 M78.5 M
Slightly volatile
Depreciation1.4 M2.2 M1.1 M
Slightly volatile
Capital Expenditures547.2 K576 K957.3 K
Slightly volatile
End Period Cash Flow34.5 M36.3 M73.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.389.877737.9863
Slightly volatile
PTB Ratio2.282.402740.7518
Slightly volatile
Days Sales Outstanding27.9729.4443155
Slightly volatile
Book Value Per Share1.631.02011.6541
Slightly volatile
Stock Based Compensation To Revenue0.160.20030.2039
Slightly volatile
Capex To Depreciation0.250.26641.0895
Pretty Stable
PB Ratio2.282.402740.7518
Slightly volatile
EV To Sales8.318.748133.2657
Slightly volatile
Payables Turnover43.929.2744.8861
Pretty Stable
Sales General And Administrative To Revenue0.580.41870.8496
Slightly volatile
Research And Ddevelopement To Revenue2.732.29123.843
Slightly volatile
Capex To Revenue0.020.02110.0853
Slightly volatile
Cash Per Share1.61.50361.6527
Slightly volatile
Days Payables Outstanding22.7712.9121.4161
Slightly volatile
Intangibles To Total Assets0.190.21830.2043
Slightly volatile
Current Ratio1.621.70568.5308
Pretty Stable
Tangible Book Value Per Share0.530.5621.4398
Slightly volatile
Receivables Turnover11.7812.396318.7081
Very volatile
Shareholders Equity Per Share1.631.02011.6484
Slightly volatile
Debt To Equity0.05080.04830.0126
Slightly volatile
Capex Per Share0.0050.00520.0144
Pretty Stable
Graham Net Net0.420.44061.3357
Slightly volatile
Revenue Per Share0.460.24810.3626
Very volatile
Interest Debt Per Share0.0530.05050.0226
Slightly volatile
Debt To Assets0.02470.02350.0087
Slightly volatile
Graham Number7.066.735.2275
Slightly volatile
Price Book Value Ratio2.282.402740.7518
Slightly volatile
Days Of Payables Outstanding22.7712.9121.4161
Slightly volatile
Ebt Per Ebit0.790.9720.9755
Pretty Stable
Company Equity Multiplier1.532.05681.7426
Slightly volatile
Long Term Debt To Capitalization0.00110.00120.0026
Slightly volatile
Total Debt To Capitalization0.04840.04610.0122
Slightly volatile
Debt Equity Ratio0.05080.04830.0126
Slightly volatile
Quick Ratio1.621.70568.5252
Pretty Stable
Net Income Per E B T1.11.00011.0083
Slightly volatile
Cash Ratio0.340.35975.9323
Very volatile
Days Of Sales Outstanding27.9729.4443155
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.130.99131.0326
Pretty Stable
Price To Book Ratio2.282.402740.7518
Slightly volatile
Fixed Asset Turnover3.213.376515.2461
Slightly volatile
Debt Ratio0.02470.02350.0087
Slightly volatile
Price Sales Ratio9.389.877737.9863
Slightly volatile
Asset Turnover0.110.11830.3327
Slightly volatile
Price Fair Value2.282.402740.7518
Slightly volatile

AC Immune Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap256.3 M269.8 M516.3 M
Slightly volatile
Enterprise Value227 M238.9 M444.4 M
Slightly volatile

ACIU Fundamental Market Drivers

Forward Price Earnings11.236
Cash And Short Term Investments165.5 M

ACIU Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
26th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About AC Immune Financial Statements

AC Immune shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although AC Immune investors may analyze each financial statement separately, they are all interrelated. The changes in AC Immune's assets and liabilities, for example, are also reflected in the revenues and expenses on on AC Immune's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue85.1 M89.3 M
Total Revenue27.3 M20.1 M
Cost Of Revenue62.8 M45.8 M
Stock Based Compensation To Revenue 0.20  0.16 
Sales General And Administrative To Revenue 0.42  0.58 
Research And Ddevelopement To Revenue 2.29  2.73 
Capex To Revenue 0.02  0.02 
Revenue Per Share 0.25  0.46 
Ebit Per Revenue(1.92)(2.01)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ACIU Stock Analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY